TTRX (Turn Therapeutics Inc. Common Stock) Stock Analysis

Turn Therapeutics Inc. Common Stock (TTRX) is a publicly traded the market company. As of May 21, 2026, TTRX trades at $4.69 with a market cap of $145.96M and a P/E ratio of -40.28. TTRX moved +0.00% today. Year to date, TTRX is +0.63%; over the trailing twelve months it is flat. Its 52-week range spans $2.57 to $26.50. Rallies surfaces TTRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest TTRX stock research?

Turn Therapeutics Inc. Common Stock (TTRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TTRX moved +0.00% today.

TTRX Key Metrics

Key financial metrics for TTRX
MetricValue
Price$4.69
Market Cap$145.96M
P/E Ratio-40.28
EPS$-0.12
Dividend Yield0.00%
52-Week High$26.50
52-Week Low$2.57
Volume1
Avg Volume0
Revenue (TTM)$0
Net Income$-3.19M
Gross Margin0.00%

Latest TTRX News

Recent TTRX Insider Trades

  • Chaudhary Zuraiz bought 2.50K (~$8.75K) on Dec 12, 2025.
  • GOLDEN ARTHUR F bought 9.87K (~$33.95K) on Nov 24, 2025.
  • GOLDEN ARTHUR F bought 20.53K (~$58.93K) on Nov 21, 2025.

TTRX Analyst Consensus

TTRX analyst coverage data. Average price target: $0.00.

Common questions about TTRX

What can I research for TTRX on Rallies?
Turn Therapeutics Inc. Common Stock (TTRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TTRX moved +0.00% today.
Does Rallies show live market data for TTRX?
Rallies combines live market context with ticker research for TTRX, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
TTRX

TTRX